Advanced Search

Uveitis Stocks List

Symbol Grade Name % Change
EYPT D EyePoint Pharmaceuticals, Inc. -1.54
XOMA D XOMA Corporation -1.58
CANF D Can-Fite Biopharma Ltd Sponsored ADR (Israel) 4.81
ALDX D Aldeyra Therapeutics, Inc. 1.10
CLSD C Clearside Biomedical, Inc. -3.53
View As Page of Charts
Related Industries: Biotechnology
Related Stock Lists: Medicine Biopharmaceutical Biotechnology Eye Immunology Inflammatory Macular Degeneration Macular Edema Non Infectious Uveitis Related Macular Degeneration Wet Age Related Macular Degeneration Acne Adverum Biotechnologies Alimera Sciences Allergy Angiotensin Angiotensin Converting Enzyme Antibodies Antibody Antibody Product

Related ETFs - A few ETFs which own one or more of the above listed Uveitis stocks.

Symbol Grade Name Weight
FDM C First Trust DJ Select MicroCap ETF 0.83
SBIO F ALPS Medical Breakthroughs ETF 0.3
IWC D iShares Microcap ETF 0.16
LABU F Direxion Daily S&P Biotech Bull 3X Shares 0.1
BTEC D Principal Healthcare Innovators Index ETF 0.06
View all Uveitis related ETFs...
Compare ETFs
  • Compare FDM to LABU
  • Compare IWC to BTEC
  • Compare IWC to LABU

    • Recent Signals

    Date Stock Signal Type
    2021-04-20 ALDX NR7 Range Contraction
    2021-04-20 CANF Stochastic Buy Signal Bullish
    2021-04-20 CLSD Stochastic Sell Signal Bearish
    2021-04-20 CLSD NR7 Range Contraction
    2021-04-20 EYPT Stochastic Reached Oversold Weakness
    2021-04-20 EYPT Narrow Range Bar Range Contraction
    2021-04-20 EYPT NR7 Range Contraction
    2021-04-20 XOMA Stochastic Reached Oversold Weakness

    Recent News for Uveitis Stocks

    Date Stock Title
    Apr 20 CANF Can-Fite Starts Preclinical Studies Required By FDA, EMA For Two Lead Drug Candidates Registration Filing
    Apr 20 CANF Can-Fite initiates preclinical studies of its two lead drug candidates
    Apr 20 CANF Can-Fite Initiates Preclinical Studies Required by FDA and EMA for the Registration of its Two Lead Drug Candidates
    Apr 19 CANF GME, CLNE, WPRT and CLOV among notable premarket gainers
    Apr 15 XOMA XOMA’s Royalty Portfolio Grows with Addition of Three Royalty Assets
    Related Industries: Biotechnology
    Related Stock Lists: Medicine Biopharmaceutical Biotechnology Eye Immunology Inflammatory Macular Degeneration Macular Edema Non Infectious Uveitis Related Macular Degeneration Wet Age Related Macular Degeneration Acne Adverum Biotechnologies Alimera Sciences Allergy Angiotensin Angiotensin Converting Enzyme Antibodies Antibody Antibody Product

    Uveitis is the inflammation of the uvea, the pigmented layer that lies between the inner retina and the outer fibrous layer composed of the sclera and cornea. The uvea consists of the middle layer of pigmented vascular structures of the eye and includes the iris, ciliary body, and choroid. Uveitis is an ophthalmic emergency and requires a thorough examination by an optometrist or ophthalmologist and urgent treatment to control the inflammation. It is often associated with other ocular problems.

    More about Uveitis
    Browse All Tags